SCHEMBL23726158

SCHEMBL23726158

Cn1c(Br)cc2nc(CN(CCO[Si](C)(C)C(C)(C)C)C(=O)O)cc(=O)n21

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30432879 0.90 SSTR4 (0.32) —
SCHEMBL25172225 0.77 DUT (0.32) —
SCHEMBL23726160 0.76 KDM4E (0.34) —
SCHEMBL23725967 0.71 MEN1 (0.34) —
SCHEMBL27030212 0.67 METTL3 (0.38) —
SCHEMBL16096650 0.67 DUT (0.36) —
SCHEMBL23725956 0.66 KDM4E (0.50) —
SCHEMBL16095967 0.63 — —
SCHEMBL23355597 0.63 GRIN2D (0.36) —
SCHEMBL18076253 0.62 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230143612-A1 SUBSTITUTED 1,1'-BIPHENYL COMPOUNDS AND METHODS USING SAME ARBUTUS BIOPHARMA CORP (US) 2023-05-11 — — US disclosed
EP-4100381-A1 SUBSTITUTED 1,1'-BIPHENYL COMPOUNDS AND METHODS USING SAME Arbutus Biopharma Corporation (CA) 2022-12-14 — — EP disclosed
WO-2021158481-A1 SUBSTITUTED 1,1'-BIPHENYL COMPOUNDS AND METHODS USING SAME ARBUTUS BIOPHARMA, INC. (US) 2021-08-12 — — WO disclosed
Send feedback